Bristol Myers Retakes Its 200-Day Line On Quarterly Beat, Surprise Immunology Win
Investor's Business DailyBristol Myers Squibb stock gapped higher Friday after the Big Pharma stalwart beat June-quarter forecasts and raised its outlook.
The post Bristol Myers Retakes Its 200-Day Line On Quarterly Beat, Surprise Immunology Win appeared first on Investor'…